475 related articles for article (PubMed ID: 38413478)
1. Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.
Kadian LK; Verma D; Lohani N; Yadav R; Ranga S; Gulshan G; Pal S; Kumari K; Chauhan SS
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38413478
[TBL] [Abstract][Full Text] [Related]
2. The Oncogenic and Tumor Suppressive Long Non-Coding RNA-microRNA-Messenger RNA Regulatory Axes Identified by Analyzing Multiple Platform Omics Data from Cr(VI)-Transformed Cells and Their Implications in Lung Cancer.
Sweef O; Yang C; Wang Z
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289596
[TBL] [Abstract][Full Text] [Related]
3. Biological Function of Long Non-coding RNA (LncRNA) Xist.
Wang W; Min L; Qiu X; Wu X; Liu C; Ma J; Zhang D; Zhu L
Front Cell Dev Biol; 2021; 9():645647. PubMed ID: 34178980
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
5. Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment.
Luo Y; Yang J; Yu J; Liu X; Yu C; Hu J; Shi H; Ma X
Front Oncol; 2020; 10():48. PubMed ID: 32083005
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.
Eptaminitaki GC; Wolff N; Stellas D; Sifakis K; Baritaki S
Cells; 2021 Nov; 10(12):. PubMed ID: 34943820
[TBL] [Abstract][Full Text] [Related]
7. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
8. The Role of Long Non-coding RNAs in Immunotherapy Resistance.
Zhou Y; Zhu Y; Xie Y; Ma X
Front Oncol; 2019; 9():1292. PubMed ID: 31850199
[TBL] [Abstract][Full Text] [Related]
9. lncRNA-mediated ceRNA network in bladder cancer.
Li K; Yao T; Wang Z
Noncoding RNA Res; 2023 Jun; 8(2):135-145. PubMed ID: 36605618
[TBL] [Abstract][Full Text] [Related]
10. Integrated Analysis of the Transcriptome Profile Reveals the Potential Roles Played by Long Noncoding RNAs in Immunotherapy for Sarcoma.
Pang B; Hao Y
Front Oncol; 2021; 11():690486. PubMed ID: 34178688
[TBL] [Abstract][Full Text] [Related]
11. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
Zhang J; Liu L; Li J; Le TD
Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
[TBL] [Abstract][Full Text] [Related]
12. Roles of Oncogenic Long Non-coding RNAs in Cancer Development.
Do H; Kim W
Genomics Inform; 2018 Dec; 16(4):e18. PubMed ID: 30602079
[TBL] [Abstract][Full Text] [Related]
13. An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer.
Martinez-Castillo M; M Elsayed A; López-Berestein G; Amero P; Rodríguez-Aguayo C
Noncoding RNA; 2023 Nov; 9(6):. PubMed ID: 37987366
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA: a dazzling dancer in tumor immune microenvironment.
Zhang Y; Liu Q; Liao Q
J Exp Clin Cancer Res; 2020 Nov; 39(1):231. PubMed ID: 33148302
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications.
Wang Y; Bu N; Luan XF; Song QQ; Ma BF; Hao W; Yan JJ; Wang L; Zheng XL; Maimaitiyiming Y
Front Oncol; 2024; 14():1337579. PubMed ID: 38505593
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity.
Saadi W; Fatmi A; Pallardó FV; García-Giménez JL; Mena-Molla S
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612180
[TBL] [Abstract][Full Text] [Related]
17. Exosomal long non-coding RNAs in cancer: Interplay, modulation, and therapeutic avenues.
Marima R; Basera A; Miya T; Damane BP; Kandhavelu J; Mirza S; Penny C; Dlamini Z
Noncoding RNA Res; 2024 Sep; 9(3):887-900. PubMed ID: 38616862
[TBL] [Abstract][Full Text] [Related]
18. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
[TBL] [Abstract][Full Text] [Related]
19. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma.
Yue Y; Tao J; An D; Shi L
Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480
[TBL] [Abstract][Full Text] [Related]
20. A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma.
Gong WJ; Zhou T; Wu SL; Huang YF; Xiang LP; Xu JQ; Han Y; Lv YN; Zeng F; Zhang Y
Ann Transl Med; 2021 Sep; 9(18):1484. PubMed ID: 34734036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
